Journal article

Going to extremes: determinants of extraordinary response and survival in patients with cancer

Flurina AM Saner, Alan Herschtal, Brad H Nelson, Anna deFazio, Ellen L Goode, Susan J Ramus, Ahwan Pandey, Jessica A Beach, Sian Fereday, Andrew Berchuck, Stephanie Lheureux, Celeste Leigh Pearce, Paul D Pharoah, Malcolm C Pike, Dale W Garsed, David DL Bowtell

Nature Reviews Cancer | NATURE PUBLISHING GROUP | Published : 2019

Grants

Awarded by Swiss National Foundation Early Postdoc Mobility Fellowship


Awarded by Swiss Cancer Research Foundation


Awarded by US Army Medical Research and Materiel Command grant


Awarded by National Health and Medical Research Council of Australia (NHMRC)


Awarded by US National Cancer Institute U54 programme


Awarded by US Army Medical Research and Materiel Command


Awarded by NATIONAL CANCER INSTITUTE


Funding Acknowledgements

F.A.M.S. is supported by a Swiss National Foundation Early Postdoc Mobility Fellowship (P2BEP3-172246), Swiss Cancer Research Foundation grant BIL KFS-3942-08-2016 and a Professor Dr Max Cloetta and Uniscientia Foundation grant. B.H.N., A.dF., C.L.P., M.C.P., D.W.G. and D.D.L.B. are supported by US Army Medical Research and Materiel Command grant W81XWH-16-2-0010. D.D.L.B. is supported by National Health and Medical Research Council of Australia (NHMRC) grants APP1092856 and APP1117044 and by the US National Cancer Institute U54 programme (U54CA209978). The authors acknowledge additional support from Margaret Rose AM and the Rose family, The WeirAnderson Foundation, Border Ovarian Cancer Awareness Group, donors to the Garvan Institute of Medical Research Ovarian Cancer Research Program, the Peter MacCallum Cancer Foundation, Wendy Taylor and Arthur Coombs and family. The Australian Ovarian Cancer Study (AOCS) was supported by the US Army Medical Research and Materiel Command under DAMD17-01-1-0729.